Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » 10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

10x Genomics Countersues Bio-Rad Laboratories in Latest Patent Infringement Lawsuit

May 18, 2020
|
staff reporter

NEW YORK – 10x Genomics has countersued Bio-Rad Laboratories in a US District Court patent infringement suit.

Last week, 10x responded to Bio-Rad's allegations that 10x's Next GEM microfluidic chips infringe US Patent No. 10,190,115, "Methods and compositions for nucleic acid analysis" which covers the partitioning of a sample into droplets, in some cases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lots of Voided Tests

Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.

Score Disparities Found

Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.

Maybe an RNA-DNA World

New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.

Nature Papers Describe Sequencing of Sperm Genomes, Approach to Detect Residual Cancer, More

In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.

What's Popular?

In Business News

  1. Twist Bioscience Prices $100M Stock Offering

  2. 10x Genomics, Collaborators Develop Targeted Single-Cell Gene Expression Methods

    Premium

  3. FDA Issues Emergency Use Authorizations for Gravity Diagnostics, Aspirus, CSI Coronavirus Tests

  4. Guardant Health Prices $315M Public Offering

  5. OraSure Technologies Prices $82.5M Stock Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.